These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1220 related articles for article (PubMed ID: 8436437)

  • 1. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression.
    Korczak B; Dennis JW
    Int J Cancer; 1993 Feb; 53(4):634-9. PubMed ID: 8436437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-linked oligosaccharide processing and autocrine stimulation of tumor cell proliferation.
    VanderElst I; Dennis JW
    Exp Cell Res; 1991 Feb; 192(2):612-21. PubMed ID: 1899075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine.
    Dennis JW; Koch K; Yousefi S; VanderElst I
    Cancer Res; 1990 Mar; 50(6):1867-72. PubMed ID: 2106389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of pentamannose oligosaccharides in human mononuclear leukocytes by action of swainsonine, an inhibitor of glycoprotein processing.
    Kang MS; Bowlin TL; Vijay IK; Sunkara SP
    Carbohydr Res; 1993 Oct; 248():327-37. PubMed ID: 8252542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis.
    Yousefi S; Higgins E; Daoling Z; Pollex-Krüger A; Hindsgaul O; Dennis JW
    J Biol Chem; 1991 Jan; 266(3):1772-82. PubMed ID: 1824844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branching N-linked oligosaccharides in breast cancer.
    Korczak B; Goss P; Fernandez B; Baker M; Dennis JW
    Adv Exp Med Biol; 1994; 353():95-104. PubMed ID: 7985545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression.
    Seftor RE; Seftor EA; Grimes WJ; Liotta LA; Stetler-Stevenson WG; Welch DR; Hendrix MJ
    Melanoma Res; 1991; 1(1):43-54. PubMed ID: 1668368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.
    Dennis JW
    Cancer Res; 1986 Oct; 46(10):5131-6. PubMed ID: 3093060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of N-linked oligosaccharide processing glucosidases interfere with oligodendrocyte differentiation in culture.
    Bhat NR; Zhang P
    J Neurosci Res; 1994 Sep; 39(1):1-10. PubMed ID: 7528816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic resistance to glycoprotein processing inhibitors in Chinese hamster ovary cells. The role of a novel mutation in the asparagine-linked glycosylation pathway.
    Lehrman MA; Zeng Y
    J Biol Chem; 1989 Jan; 264(3):1584-93. PubMed ID: 2521484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonoyloxy analogs of the anti-metastatic drug swainsonine. Activation in tumor cells by esterases.
    Dennis JW; White SL; Freer AM; Dime D
    Biochem Pharmacol; 1993 Oct; 46(8):1459-66. PubMed ID: 8240396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endomannosidase inhibitors and evaluation of their effect on N-linked oligosaccharide processing during glycoprotein biosynthesis.
    Hiraizumi S; Spohr U; Spiro RG
    J Biol Chem; 1993 May; 268(13):9927-35. PubMed ID: 8486671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glycosylation. The influence of protein structure on N-linked oligosaccharide processing.
    Hubbard SC
    J Biol Chem; 1988 Dec; 263(36):19303-17. PubMed ID: 3198629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialylation and malignant potential in tumour cell glycosylation mutants.
    Takano R; Muchmore E; Dennis JW
    Glycobiology; 1994 Oct; 4(5):665-74. PubMed ID: 7881181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell surface carbohydrate and the metastatic phenotype.
    Dennis JW; Laferte S
    Cancer Metastasis Rev; 1987; 5(3):185-204. PubMed ID: 3549035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells.
    Humphries MJ; Matsumoto K; White SL; Olden K
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1752-6. PubMed ID: 3081900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subclass of cell surface carbohydrates revealed by a CHO mutant with two glycosylation mutations.
    Stanley P; Sundaram S; Sallustio S
    Glycobiology; 1991 Jun; 1(3):307-14. PubMed ID: 1838951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that beta 1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes.
    Yagel S; Feinmesser R; Waghorne C; Lala PK; Breitman ML; Dennis JW
    Int J Cancer; 1989 Oct; 44(4):685-90. PubMed ID: 2507455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of glycoproteins by N-acetylglucosaminyltransferase V is greatly influenced by accessibility of the enzyme to oligosaccharide acceptors.
    Do KY; Fregien N; Pierce M; Cummings RD
    J Biol Chem; 1994 Sep; 269(38):23456-64. PubMed ID: 7522229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.